AAPS NBC 2026

May 11-14, 2026

Sheraton San Diego Resort  |  San Diego , CA

Connect With Us at AAPS National Biotechnology Conference (NBC) 2026

BioData Solutions is excited to participate in one of the leading events for biopharmaceutical development, bioanalysis, and translational science, bringing together experts across biologics, cell and gene therapy (CGT), pharmacokinetics (PK), and immunogenicity.

Featured Presentation

Joleen White, PhD

Wednesday, May 13  |  2:30 PM – 3:30 PM PT

This session will focus on one of the most critical transitions in drug development – moving from first-in-human (FIH) studies to registrational trials. Attendees will gain insights into:

• Evolving bioanalytical strategies across clinical phases
• Ensuring data consistency and assay comparability from early to late-stage development
• Addressing regulatory expectations for PK, ADA, and biomarker data
• Supporting robust, submission-ready datasets for BLA/NDA filings

This presentation is particularly relevant for bioanalytical scientists, clinical pharmacology teams, and regulatory professionals navigating phase transitions in biologics and advanced therapies.

Meet the BioData Solutions Team

Joining the conference are:

• Joleen White, PhD – Presenter and an expert in immunogenicity, regulatory submissions, and biomarkers
• Stephanie Pasas Farmer, PhD – Bioanalytical leader with expertise in cell and gene therapy, immunogenicity, and bioanalytical and regulatory strategy

Connect With Us at NBC 2026

Whether you are:

• Transitioning from early clinical development to registrational studies
• Evaluating bioanalytical strategy for biologics or CGT programs
• Planning for regulatory submissions and data integrity requirements

We welcome the opportunity to connect, exchange perspectives, and discuss your program goals.

Connect with us ahead of time or meet us onsite during the conference.